Inventor
XU CEN
US18 patents
⚠️ This page may combine multiple inventors who share the name “XU CEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
17 patentsUS9365653B2Jun 14, 2016
Human PAC1 antibodies
AMGEN INC24 citations94
US10053507B2Aug 21, 2018
Human PAC1 antibodies
AMGEN INC6 citations84
US9822178B2Nov 21, 2017
Human PAC1 antibodies
AMGEN INC6 citations84
US9676851B2Jun 13, 2017
Human PAC1 antibodies
AMGEN INC6 citations84
US9862771B2Jan 9, 2018
Human CGRP receptor binding proteins
AMGEN INC8 citations82
US10822408B2Nov 3, 2020
PACAP antibodies and uses thereof
AMGEN INC10 citations79
US10934362B2Mar 2, 2021
Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof
AMGEN INC5 citations72
US11891435B2Feb 6, 2024
Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof
AMGEN INC1 citations71
US11248043B2Feb 15, 2022
Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof
AMGEN INC1 citations71
US10738110B2Aug 11, 2020
PAC1 antibodies and uses thereof
AMGEN INC3 citations71
US12134652B2Nov 5, 2024
Human CGRP receptor binding proteins
AMGEN INC0 citations61
US12122841B2Oct 22, 2024
Human CGRP receptor binding proteins
AMGEN INC0 citations61
US11919964B2Mar 5, 2024
Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof
AMGEN INC0 citations61
US11780914B2Oct 10, 2023
PACAP antibodies and uses thereof
AMGEN INC0 citations57
US10793631B2Oct 6, 2020
Human PAC1 antibodies
AMGEN INC0 citations52
US10472417B2Nov 12, 2019
Human PAC1 antibodies
AMGEN INC0 citations52
US10294298B2May 21, 2019
Human PAC1 antibodies
AMGEN INC0 citations52